Regenxbio Inc (RGNX)
8.77
-0.02
(-0.23%)
USD |
NASDAQ |
Nov 04, 13:10
Regenxbio 1 Year Total Returns (Daily): -38.06% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | -38.06% |
October 31, 2024 | -33.36% |
October 30, 2024 | -38.48% |
October 29, 2024 | -37.00% |
October 28, 2024 | -34.77% |
October 25, 2024 | -39.95% |
October 24, 2024 | -39.79% |
October 23, 2024 | -37.44% |
October 22, 2024 | -40.66% |
October 21, 2024 | -35.83% |
October 18, 2024 | -30.54% |
October 17, 2024 | -35.80% |
October 16, 2024 | -33.85% |
October 15, 2024 | -35.99% |
October 14, 2024 | -36.61% |
October 11, 2024 | -41.17% |
October 10, 2024 | -44.77% |
October 09, 2024 | -42.50% |
October 08, 2024 | -39.84% |
October 07, 2024 | -40.09% |
October 04, 2024 | -35.88% |
October 03, 2024 | -43.33% |
October 02, 2024 | -38.27% |
October 01, 2024 | -37.97% |
September 30, 2024 | -36.27% |
Date | Value |
---|---|
September 27, 2024 | -38.64% |
September 26, 2024 | -37.80% |
September 25, 2024 | -35.84% |
September 24, 2024 | -34.48% |
September 23, 2024 | -31.79% |
September 20, 2024 | -33.47% |
September 19, 2024 | -30.17% |
September 18, 2024 | -29.65% |
September 17, 2024 | -27.17% |
September 16, 2024 | -28.35% |
September 13, 2024 | -28.75% |
September 12, 2024 | -29.68% |
September 11, 2024 | -26.57% |
September 10, 2024 | -31.57% |
September 09, 2024 | -33.84% |
September 06, 2024 | -35.03% |
September 05, 2024 | -34.75% |
September 04, 2024 | -37.78% |
September 03, 2024 | -37.45% |
August 30, 2024 | -33.66% |
August 29, 2024 | -34.75% |
August 28, 2024 | -36.12% |
August 27, 2024 | -36.03% |
August 26, 2024 | -33.28% |
August 23, 2024 | -32.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.16%
Minimum
Mar 18 2020
82.79%
Maximum
Mar 18 2021
-18.25%
Average
-20.26%
Median
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 61.12% |
Catalyst Pharmaceuticals Inc | 73.18% |
Vertex Pharmaceuticals Inc | 27.56% |
Edgewise Therapeutics Inc | 427.1% |
Entrada Therapeutics Inc | 13.55% |